KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Novartis Ag (NVS) Gross Margin (2016 - 2025)

Historic Gross Margin for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to 1237.8%.

  • Novartis Ag's Gross Margin rose 11599900.0% to 1237.8% in Q4 2025 from the same period last year, while for Dec 2025 it was 1307.82%, marking a year-over-year increase of 12305200.0%. This contributed to the annual value of 78.81% for FY2025, which is 15100.0% up from last year.
  • Novartis Ag's Gross Margin amounted to 1237.8% in Q4 2025, which was up 11599900.0% from 1482.05% recorded in Q3 2025.
  • In the past 5 years, Novartis Ag's Gross Margin registered a high of 1581.89% during Q1 2025, and its lowest value of 69.74% during Q1 2021.
  • For the 5-year period, Novartis Ag's Gross Margin averaged around 328.42%, with its median value being 75.78% (2022).
  • In the last 5 years, Novartis Ag's Gross Margin plummeted by -34200bps in 2021 and then surged by 15056000bps in 2025.
  • Novartis Ag's Gross Margin (Quarter) stood at 72.16% in 2021, then grew by 4bps to 74.93% in 2022, then grew by 2bps to 76.63% in 2023, then rose by 2bps to 77.81% in 2024, then soared by 1491bps to 1237.8% in 2025.
  • Its last three reported values are 1237.8% in Q4 2025, 1482.05% for Q3 2025, and 1075.07% during Q2 2025.